Cadus Buy or Sell Recommendation

Macroaxis provides Cadus Corporation buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Cadus positions. The advice algorithm takes into account all of Cadus Corporation available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Cadus buy-and-hold prospective. Please see also Cadus Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Time Horizon

Risk Tolerance

Execute Advice
Cadus Corporation -- USA Stock  

USD 1.59  0.01  0.63%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Cadus Corporation is 'Strong Hold'.
For the selected time horizon Cadus Corporation has a risk adjusted performance of 0.1502, jensen alpha of 0.0217, total risk alpha of 0.0407, sortino ratio of 0.0 and treynor ratio of 1.1
We provide buy or sell advice to complement the prevailing expert consensus on Cadus. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at the time. To make sure Cadus is not overpriced, please confirm all Cadus fundamentals including its EBITDA as well as the relationship between Cash Flow from Operations and Retained Earnings . Please also double-check Cadus Corporation Price to Earning to validate your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Returns Distribution Density

Mean Return0.02895Value At Risk0.00
Potential Upside0.63Standard Deviation0.24
 Return Density 

Institutional Investors

Security TypeSharesValue
Fny Managed Accounts LlcCommon Shares11.2 K16 K
Messner Smith Theme Value Investment Management LtdCommon Shares2 K3 K
Messner Smith Theme Value Investment Management LtdCommon Shares21 K26 K
Messner Smith Theme Value Investment Management LtdCommon Shares2 K2 K
Messner Smith Theme Value Investment Management LtdCommon Shares2 K2 K
Messner Smith Theme Value Investment Management LtdCommon Shares2 K2 K

Cadus Greeks

Alpha over DOW
Beta against DOW=0.0172
Overall volatility
Information ratio =0.76

Cadus Volatility Alert

Cadus Corporation exhibits very low volatility with skewness of 0.61 and kurtosis of 5.65. However, we advise investors to further study Cadus Corporation technical indicators to make sure all market info is available and is reliable.
 Better Than Average     
 Worse Than Average Compare Cadus to competition
FundamentalsCadusPeer Average
Return On Equity(3.64) % (15.17) %
Return On Asset(2.28) % (15.64) %
Current Valuation37.97 M152.14 B
Shares Outstanding26.29 M1.43 B
Shares Owned by Insiders0.09 % 6.91 %
Shares Owned by Institutions69.00 % 18.37 %
Price to Earning36.54 times40.69 times
Price to Book1.05 times14.44 times
EBITDA(1.49 M)1.41 B
Net Income(1.47 M)517.71 M
Cash and Equivalents3.83 M3.89 B
Cash per Share0.15 times5.17 times
Current Ratio6.19 times3.30 times
Book Value Per Share1.51 times13.64 times
Cash Flow from Operations(2.85 M)1.25 B
Earnings Per Share0.06 times2.30 times
Number of Employees510.67 K
Market Capitalization41.8 M29.78 B
Total Asset41.5 M126.86 B
Retained Earnings(39.16 M)38.24 B
Working Capital40.89 M3.58 B
Current Asset41.29 M36.8 B
Current Liabilities399 K33.34 B
Strong Hold

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Currently Unavailable

Piotroski F Score

Financial Leverage

Risk Adjusted Performance0.1502
Market Risk Adjusted Performance1.11
Mean Deviation0.1098
Coefficient Of Variation818.22
Standard Deviation0.2369
Information Ratio0.7601
Jensen Alpha0.0217
Total Risk Alpha0.0407
Treynor Ratio1.1
Maximum Drawdown1.26
Potential Upside0.6329

Current Valuation

Cadus Current Valuation Analysis
Cadus Corporation is rated below average in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Biotechnology industry is now estimated at about 88.34 Billion. Cadus adds roughly 37.97 Million in current valuation claiming only tiny portion of stocks in Biotechnology industry.